AstraZeneca revises vaccine efficacy to 76 per cent
AstraZeneca said its COVID-19 vaccine is 76 percent effective for preventing symptomatic illness after a new analysis of updated U.S. ...
Tag: NIAID
Latest News
AstraZeneca said its COVID-19 vaccine is 76 percent effective for preventing symptomatic illness after a new analysis of updated U.S. ...